JMP Securities Initiates Coverage on Loxo Oncology (LOXO)
Investment analysts at JMP Securities initiated coverage on shares of Loxo Oncology (NASDAQ:LOXO) in a note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating on the stock.
Loxo Oncology (NASDAQ:LOXO) opened at 13.05 on Tuesday. Loxo Oncology has a one year low of $12.72 and a one year high of $13.42. The stock has a 50-day moving average of $13.04 and a 200-day moving average of $13.04. The company’s market cap is $208.0 million.
Loxo Oncology, Inc (NASDAQ:LOXO) develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.